Home-based aerobic exercise feasibility in oxaliplatin-receiving newly-diagnosed cancer survivors.

Autor: Kanzawa-Lee GA; School of Nursing, University of Michigan, Ann Arbor, MI, USA; Smith's Currently at School of Nursing, University of Alabama, Birmingham, AL, USA. Electronic address: gracekan@umich.edu., Larson JL; School of Nursing, University of Michigan, Ann Arbor, MI, USA; Smith's Currently at School of Nursing, University of Alabama, Birmingham, AL, USA., Resnicow K; School of Public Health, University of Michigan, Ann Arbor, MI, USA., Ploutz-Snyder R; School of Nursing, University of Michigan, Ann Arbor, MI, USA., Krauss JC; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Smith EML; School of Nursing, University of Michigan, Ann Arbor, MI, USA; Smith's Currently at School of Nursing, University of Alabama, Birmingham, AL, USA.
Jazyk: angličtina
Zdroj: European journal of oncology nursing : the official journal of European Oncology Nursing Society [Eur J Oncol Nurs] 2024 Aug; Vol. 71, pp. 102649. Date of Electronic Publication: 2024 Jun 27.
DOI: 10.1016/j.ejon.2024.102649
Abstrakt: Purpose: Physical activity (PA) is beneficial but difficult to maintain during chemotherapy. This pilot RCT explored the feasibility of the MI-Walk intervention-an 8-week motivational enhancement therapy- and home-based brisk walking intervention-among gastrointestinal (GI) cancer survivors receiving chemotherapy.
Methods: Sixty stage II-IV GI cancer survivors were recruited from 5 sites at their second infusion visit. Participants were randomized to receive PA education alone or the MI-Walk intervention: motivational enhancement therapy consisting of 3 motivational interviewing and self-efficacy-enhancing counseling sessions, a Fitbit Charge 2, exercise diaries, telephone follow-up, scripted motivational email messages, and optional weekly walking groups.
Results: The enrollment and completion rates were 62% and 90%, respectively. The MI-Walk participants (n = 29; mean age = 56.79, SD = 11.72; 97% white; 79% male) reported a baseline moderate-vigorous PA duration of 250.93 (SD = 636.52) min/wk. The mean MI-Walk Intervention acceptability score was 50.32 (SD = 12.02) on a scale of 14-70. Mean Fitbit and counseling helpfulness scores on a 5-point scale were 3.67 (SD = 1.43) and 3.44 (SD = 1.36), respectively. Participants' Fitbit moderate-vigorous PA 8-week averages ranged from 0 to 716.88 min/wk; 64% of participants adhered to ≥127 min/wk. Several characteristics (e.g., age, comorbidity, PA level, employment status, BMI, education level, gender, symptoms) were associated with enrollment, attrition, and intervention acceptability and adherence (p < 0.05).
Conclusion: Enrollment and retention were adequate. The Fitbit and counseling were the most helpful. Acceptability and adherence varied based on participant characteristics; therefore, intervention tailoring and further research among cancer survivors less physically active at baseline and most in need of complex exercise intervention are needed.
Clinicaltrials: gov NCT03515356.
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Grace Kanzawa-Lee reports financial support was provided by American Cancer Society - Denny Hoelzer Sentinel Technologies Doctoral Scholarship in Cancer Nursing. Grace Kanzawa-Lee reports financial support was provided by The Rita & Alex Hillman Foundation. Grace Kanzawa-Lee reports financial support was provided by University of Michigan Rackham Graduate School. Grace Kanzawa-Lee reports financial support was provided by University of Michigan School of Nursing.
(Copyright © 2024 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE